These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 31529338)

  • 1. Cell surface-anchored serine proteases in cancer progression and metastasis.
    Martin CE; List K
    Cancer Metastasis Rev; 2019 Sep; 38(3):357-387. PubMed ID: 31529338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression.
    Pawar NR; Buzza MS; Antalis TM
    Cancer Res; 2019 Jan; 79(2):301-310. PubMed ID: 30610085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-anchored serine proteases in health and disease.
    Antalis TM; Bugge TH; Wu Q
    Prog Mol Biol Transl Sci; 2011; 99():1-50. PubMed ID: 21238933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer.
    Netzel-Arnett S; Hooper JD; Szabo R; Madison EL; Quigley JP; Bugge TH; Antalis TM
    Cancer Metastasis Rev; 2003; 22(2-3):237-58. PubMed ID: 12784999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type II transmembrane serine proteases as potential targets for cancer therapy.
    Murray AS; Varela FA; List K
    Biol Chem; 2016 Sep; 397(9):815-26. PubMed ID: 27078673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of type II transmembrane serine protease-mediated signaling in cancer.
    Tanabe LM; List K
    FEBS J; 2017 May; 284(10):1421-1436. PubMed ID: 27870503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.
    Dorn J; Beaufort N; Schmitt M; Diamandis EP; Goettig P; Magdolen V
    Crit Rev Clin Lab Sci; 2014 Apr; 51(2):63-84. PubMed ID: 24490956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden.
    Martin EW; Buzza MS; Driesbaugh KH; Liu S; Fortenberry YM; Leppla SH; Antalis TM
    Oncotarget; 2015 Oct; 6(32):33534-53. PubMed ID: 26392335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.
    Harbig A; Mernberger M; Bittel L; Pleschka S; Schughart K; Steinmetzer T; Stiewe T; Nist A; Böttcher-Friebertshäuser E
    J Biol Chem; 2020 Aug; 295(33):11388-11407. PubMed ID: 32303635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin.
    Szabo R; Lantsman T; Peters DE; Bugge TH
    Development; 2016 Aug; 143(15):2818-28. PubMed ID: 27385010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer.
    Kim S
    Exp Mol Med; 2023 Apr; 55(4):716-724. PubMed ID: 37009799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.
    Antalis TM; Buzza MS; Hodge KM; Hooper JD; Netzel-Arnett S
    Biochem J; 2010 Jun; 428(3):325-46. PubMed ID: 20507279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers.
    Mukai S; Yamasaki K; Fujii M; Nagai T; Terada N; Kataoka H; Kamoto T
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.
    Reid JC; Matsika A; Davies CM; He Y; Broomfield A; Bennett NC; Magdolen V; Srinivasan B; Clements JA; Hooper JD
    Am J Cancer Res; 2017; 7(11):2257-2274. PubMed ID: 29218249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
    Damalanka VC; Janetka JW
    Future Med Chem; 2019 Apr; 11(7):743-769. PubMed ID: 30945556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that cell surface localization of serine protease activity facilitates cleavage of the protease activated receptor CDCP1.
    He Y; Reid JC; He H; Harrington BS; Finlayson B; Khan T; Hooper JD
    Biol Chem; 2018 Sep; 399(9):1091-1097. PubMed ID: 29447112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong expression association between matriptase and its substrate prostasin in breast cancer.
    Bergum C; Zoratti G; Boerner J; List K
    J Cell Physiol; 2012 Apr; 227(4):1604-9. PubMed ID: 21678412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TMPRSS4 during cancer progression.
    Choi SY; Shin HC; Kim SY; Park YW
    Drug News Perspect; 2008 Oct; 21(8):417-23. PubMed ID: 19034347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibuprofen regulates the expression and function of membrane-associated serine proteases prostasin and matriptase.
    Chai AC; Robinson AL; Chai KX; Chen LM
    BMC Cancer; 2015 Dec; 15():1025. PubMed ID: 26715240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-anchored serine proteases as regulators of epithelial function.
    Szabo R; Bugge TH
    Biochem Soc Trans; 2020 Apr; 48(2):517-528. PubMed ID: 32196551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.